Teva Pharmaceutical Industries — Fact Sheet (2023)

1 slide from Teva Pharmaceutical Industries's fact sheet, 2023

Slide 1: Q2 2023 Debt Analysis
Investor Relations Web: http://ir.tevapharm.com Email: TevaIR@tevapharm.com Q2 2023 Debt Analysis Debt Maturities ($ billion) 3.4 3.0 CHF EUR USD 2.5 2.1 2.0 1.8 1.6 1.6 1.0 1.0 0.8 23 24 25 26 27 28 29 30 31 … 36 … 46 Moody’s Ba2/Stable $18.0B Net Debt S&P BB-/Positive Duration 6.2 $20.7B Gross Deb